Resonant Expands Biorepository Network With Creapharm Deal
Bailly-Romainvilliers, France — September 3, 2026 Resonant Clinical Solutions announced the acquisition of Creapharm Bioservices from Myonex, strengthening its...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Bailly-Romainvilliers, France — September 3, 2026 Resonant Clinical Solutions announced the acquisition of Creapharm Bioservices from Myonex, strengthening its...
Philadelphia, Pennsylvania, August 3, 2026 Signant Health announced the launch of Forecasting & Planning Assist™, a purpose-built agentic AI...
Raleigh, North Carolina | April 13, 2026 Endpoint Clinical has announced the release of Elosity® R3, a major upgrade...
